RNA-seq data showed a significant difference between NAFLD-SD and NAFLD (Figure 1C), and the KEGG pathway analysis showed that the main differential pathways included metabolism and inflammation, with the PPAR signaling pathway closely associated with them (Figure 1D). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.